Blinatumomab Intravenous and Daunorubicin and Cytarabine (Liposomal)
Determining the interaction of Blinatumomab Intravenous and Daunorubicin and Cytarabine (Liposomal) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Blinatumomab Intravenous-Daunorubicin and cytarabine liposome Intravenous
- Blinatumomab Intravenous-Daunorubicin citrate
- Blinatumomab Intravenous-Daunorubicin citrate liposome Intravenous
- Blinatumomab Intravenous-Daunorubicin hydrochloride
- Blinatumomab Intravenous-Daunorubicin Intravenous
- Blinatumomab Intravenous-DaunoXome
- Daunorubicin and Cytarabine (Liposomal)-Blincyto
- Daunorubicin and Cytarabine (Liposomal)-Blisovi 24 Fe
- Daunorubicin and Cytarabine (Liposomal)-Blisovi 24 FE birth control
- Daunorubicin and Cytarabine (Liposomal)-Blisovi Fe 1.5/30
- Daunorubicin and Cytarabine (Liposomal)-Blisovi Fe 1/20
- Daunorubicin and Cytarabine (Liposomal)-Blocadren